Stockreport

Sensorion Announces it Has Met Primary Endpoint for SENS-401 Phase 2a Clinical Study for Residual Hearing Preservation [Yahoo! Finance]

COCHLEAR PLC UNSP/ADR  (CHEOY) 
PDF MONTPELLIER, France, March 11, 2024 BUSINESS WIRE )--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which special [Read more]